The Lancet. Oncology · 2024
Fertility-sparing treatment and follow-up in patients with cervical cancer, ovarian cancer, and borderline ovarian tumours: guidelines from ESGO, ESHRE, and ESGE.
СтатьяКлинические рекомендацииНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Morice Philippe, Scambia Giovanni, Abu-Rustum Nadeem R, Acien Maribel, Arena Alessandro, Brucker Sara, Cheong Ying, Collinet Pierre, Fanfani Francesco, Filippi Francesca, Eriksson Ane Gerda Zahl, Gouy Sebastien, Harter Philipp, Matias-Guiu Xavier, Pados George, Pakiz Maja, Querleu Denis, Rodolakis Alexandros, Rousset-Jablonski Christine, Stepanyan Artem, Testa Antonia Carla, Macklon Kirsten Tryde, Tsolakidis Dimitrios, De Vos Michel, Planchamp François, Grynberg Michaël
Аннотация
The European Society of Gynaecological Oncology, the European Society of Human Reproduction and Embryology, and the European Society for Gynaecological Endoscopy jointly developed clinically relevant and evidence-based guidelines focusing on key aspects of fertility-sparing strategies and follow-up of patients with cervical cancers, ovarian cancers, and borderline ovarian tumours. The developmental process of these guidelines is based on a systematic literature review and critical appraisal involving an international multidisciplinary development group consisting of 25 experts from relevant disciplines (ie, gynaecological oncology, oncofertility, reproductive surgery, endoscopy, imaging, conservative surgery, medical oncology, and histopathology). Before publication, the guidelines were reviewed by 121 independent international practitioners in cancer care delivery and patient representatives. The guidelines comprehensively cover oncological aspects of fertility-sparing strategies during the initial management, optimisation of fertility results and infertility management, and the patient's desire for future pregnancy and beyond.